Taka-Q Co., Ltd.
Taka-Q Co., Ltd. (8166.T) Financial Performance & Income Statement Overview
Explore the financials of Taka-Q Co., Ltd. (8166.T), including yearly and quarterly data on income, cash flow, and balance sheets.
Taka-Q Co., Ltd. (8166.T) Income Statement & Financial Overview
Access detailed annual and quarterly income data for Taka-Q Co., Ltd. 8166.T financial performance.
Metric | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 |
---|---|---|---|---|
Revenue | $2.54B | $2.41B | $2.04B | $2.66B |
Cost of Revenue | $1.10B | $955.53M | $776.67M | $1.04B |
Gross Profit | $1.44B | $1.46B | $1.26B | $1.61B |
Gross Profit Ratio | $0.57 | $0.60 | $0.62 | $0.61 |
R&D Expenses | $0.00 | $0.00 | $0.00 | $0.00 |
SG&A Expenses | $1.43B | $1.37B | $1.36B | $1.41B |
Operating Expenses | $1.43B | $1.37B | $1.36B | $1.41B |
Total Costs & Expenses | $2.53B | $2.32B | $2.14B | $2.45B |
Interest Income | $0.00 | $0.00 | $0.00 | $0.00 |
Interest Expense | $12.12M | $11.95M | $11.63M | $19.76M |
Depreciation & Amortization | $33.72M | $38.40M | $37.02M | $38.19M |
EBITDA | $91.94M | $176.73M | -$12.79M | $1.79B |
EBITDA Ratio | $0.04 | $0.07 | -$0.006 | $0.67 |
Operating Income | $10.58M | $91.49M | -$100.36M | $201.88M |
Operating Income Ratio | $0.004 | $0.04 | -$0.05 | $0.08 |
Other Income/Expenses (Net) | $42.36M | $34.89M | $38.93M | $1.53B |
Income Before Tax | $52.94M | $126.39M | -$61.44M | $1.73B |
Income Before Tax Ratio | $0.02 | $0.05 | -$0.03 | $0.65 |
Income Tax Expense | -$174.26M | $16.79M | $17.08M | $17.85M |
Net Income | $227.19M | $109.60M | -$78.52M | $1.71B |
Net Income Ratio | $0.09 | $0.05 | -$0.04 | $0.64 |
EPS | $8.70 | $4.50 | -$3.22 | $70.20 |
Diluted EPS | $8.70 | $4.50 | -$3.22 | $55.29 |
Weighted Avg Shares Outstanding | $26.11M | $24.37M | $24.37M | $24.36M |
Weighted Avg Shares Outstanding (Diluted) | $26.11M | $24.37M | $24.37M | $30.94M |
Over the past four quarters, Taka-Q Co., Ltd. demonstrated steady revenue growth, increasing from $2.66B in Q1 2024 to $2.54B in Q4 2024. Operating income reached $10.58M in Q4 2024, maintaining a consistent 0% margin over recent quarters. Despite fluctuations in R&D and SG&A expenses, EBITDA remained robust at $91.94M, reflecting operational efficiency. Net income rose to $227.19M, with EPS at $8.70. Disciplined expense management helped sustain profitability, highlighting solid overall financial performance.
Unlock 25+ Years of Financial Data
Get access to extended historical data, advanced metrics, and more with our premium plan